Serial Number | 78931095 |
Word Mark | INSTATAB |
Filing Date | Monday, July 17, 2006 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, April 25, 2011 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | Tuesday, January 1, 2008 |
Goods and Services | Pharmaceutical preparations and substances for the prevention, treatment and alleviation of stress; pharmaceutical preparations and substances for the prevention, treatment and alleviation of diabetes; pharmaceutical preparations and substances for controlling insulin levels; pharmaceutical preparations and substances for the prevention, treatment and alleviation of hypertension; pharmaceutical preparations and substances for the prevention, treatment and alleviation of angina; pharmaceutical preparations and substances for the cessation of smoking; pharmaceutical preparations and substances for the prevention and treatment of sexually transmitted diseases; pharmaceutical preparations and substances for the prevention and treatment of herpes; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the central nervous system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of depression; anti-depressants; pharmaceutical preparations and substances for the prevention, treatment and alleviation of sleep disorders; pharmaceutical preparations and substances for the prevention, treatment and alleviation of anxiety; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the cardio-vascular system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of acute myocardial infarctions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of symptomatic congestive heart failure; pharmaceutical preparations and substances for the prevention, treatment and alleviation of asymptomatic left ventricular dysfunction; pharmaceutical preparations and substances, namely, fibrinolytic or thrombolytic agents; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the respiratory system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the endocrine system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the immune system; pharmaceutical preparations and substances for the prevention, treatment and alleviation of disorders, diseases, conditions and ailments of the musculo-skeletal system, namely, bone diseases and bone degenerative conditions; pharmaceutical preparations and substances for the prevention, treatment and alleviation of pain and inflammation, namely, pain relief medication and anti-inflammatories; pharmaceutical preparations and substances for the prevention, treatment and alleviation of migraines; pharmaceutical preparations and substances, namely, medicated skin care preparations for use in dermatology, namely, dermatitis and skin pigmentation diseases; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations and substances for use in ophthalmology; pharmaceutical preparations and substances for the treatment of polycystic ovary syndrome; pharmaceutical preparations and substances for the treatment of infertility; pharmaceutical preparations and substances for the prevention, treatment and alleviation of circulatory, neurologic, alimentary, auto-immune, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral, urinary, renal, infectious or metabolic diseases, illnesses, disorders or conditions; metformin; diltiazem; tramadol; carvedilol; bupropion; metoprolol; citalopram; zolpidem; fluoxetine; venlafaxine; lorazepam; and sumatriptan; rapidly dissolving drug delivery agents consisting of compounds that facilitate the delivery of a wide variety of pharmaceuticals |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Friday, July 21, 2006 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Biovail Laboratories International SRL |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 99 - Other |
Address | Christ Church BB17154 BB |
Party Name | Biovail Laboratories International SRL |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | St. Michael BB |
Event Date | Event Description |
Wednesday, January 22, 2014 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, January 22, 2014 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Monday, April 25, 2011 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
Monday, April 25, 2011 | ABANDONMENT - NO USE STATEMENT FILED |
Wednesday, April 6, 2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, March 23, 2011 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, October 13, 2010 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Saturday, October 2, 2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Friday, October 1, 2010 | EXTENSION 5 GRANTED |
Tuesday, September 21, 2010 | EXTENSION 5 FILED |
Tuesday, September 21, 2010 | TEAS EXTENSION RECEIVED |
Tuesday, April 13, 2010 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Monday, April 12, 2010 | EXTENSION 4 GRANTED |
Wednesday, March 17, 2010 | EXTENSION 4 FILED |
Monday, April 12, 2010 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Wednesday, March 17, 2010 | TEAS EXTENSION RECEIVED |
Friday, September 18, 2009 | EXTENSION 3 GRANTED |
Tuesday, September 15, 2009 | EXTENSION 3 FILED |
Tuesday, September 15, 2009 | TEAS EXTENSION RECEIVED |
Wednesday, June 17, 2009 | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY |
Wednesday, April 8, 2009 | EXTENSION 2 GRANTED |
Tuesday, March 24, 2009 | EXTENSION 2 FILED |
Wednesday, April 8, 2009 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Tuesday, March 24, 2009 | TEAS EXTENSION RECEIVED |
Thursday, January 22, 2009 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
Thursday, January 22, 2009 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
Friday, September 19, 2008 | EXTENSION 1 GRANTED |
Friday, September 19, 2008 | EXTENSION 1 FILED |
Friday, September 19, 2008 | TEAS EXTENSION RECEIVED |
Tuesday, March 25, 2008 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, February 5, 2008 | CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED |
Tuesday, February 5, 2008 | ASSIGNED TO EXAMINER |
Monday, January 14, 2008 | FAX RECEIVED |
Tuesday, January 1, 2008 | PUBLISHED FOR OPPOSITION |
Wednesday, December 12, 2007 | NOTICE OF PUBLICATION |
Friday, November 23, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
Friday, November 23, 2007 | ASSIGNED TO LIE |
Thursday, October 18, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Saturday, September 29, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, September 27, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Thursday, September 27, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Thursday, September 27, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Thursday, September 27, 2007 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Wednesday, March 28, 2007 | FINAL REFUSAL E-MAILED |
Wednesday, March 28, 2007 | FINAL REFUSAL WRITTEN |
Saturday, March 10, 2007 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Friday, March 9, 2007 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Friday, March 9, 2007 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Wednesday, December 13, 2006 | NON-FINAL ACTION E-MAILED |
Wednesday, December 13, 2006 | NON-FINAL ACTION WRITTEN |
Wednesday, December 13, 2006 | ASSIGNED TO EXAMINER |
Friday, July 21, 2006 | NEW APPLICATION ENTERED IN TRAM |